Cholangiocarcinoma Foundation's Calendar of Events
unless otherwise stated, all times are in Eastern Time, UTC -4.
Events in June 2022
June 3, 2022 (1 event)
June 3, 2022 – June 7, 2022June 4, 2022 (1 event)
June 3, 2022 – June 7, 2022June 5, 2022 (3 events)
June 3, 2022 – June 7, 2022
June 5, 2022–
June 5, 2022June 6, 2022 (1 event)
June 3, 2022 – June 7, 2022June 7, 2022 (1 event)
June 3, 2022 – June 7, 2022June 9, 2022 (1 event)
–
June 9, 2022June 15, 2022 (1 event)
–
June 15, 2022June 17, 2022 (1 event)
–
June 17, 2022June 27, 2022 (1 event)
–
June 27, 2022In this webinar, Steven C. Katz, M.D., FACS, Chief Medical Officer at TriSalus Life Sciences®️, leads a review of the Pressure-Enabled Regional Immuno-Oncology (PERIO™️-02) clinical trial for adults with intrahepatic cholangiocarcinoma and hepatocellular carcinoma, the most common primary liver tumors. Dr. Katz is joined by Milind Javle, M.D., Professor of GI Medical Oncology at MD Anderson Cancer Center and Rahul Sheth, M.D., Associate Professor in the Department of Interventional Radiology at the MD Anderson Cancer Center.
The PERIO-02 trial is evaluating SD-101, an investigational toll-like receptor 9 (TLR9) agonist, delivered intravascularly by the TriNav®️ Infusion System using the Pressure-Enabled Drug Delivery™️ (PEDD™️) method of administration. The study objective is to understand the ability of this platform to overcome two major challenges of treatment: immune response suppression and ineffective drug delivery.
June 29, 2022 (1 event)
June 29, 2022 – July 2, 2022June 30, 2022 (1 event)
June 29, 2022 – July 2, 2022